# CARVYKTI

NDC: 57894-111
Generic name: ciltacabtagene autoleucel
Labeler / Manufacturer: Janssen Biotech, Inc.
Product type: CELLULAR THERAPY
Marketing category: Biologic License Application
Dosage form: INJECTION, SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20220228

FDA application: BLA125746

## Active ingredients

- CILTACABTAGENE AUTOLEUCEL: 100000000 1/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"57894-111"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=57894-111
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7d040b91-3fb8-41db-ba7f-60a36f06e2c2